Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer

By metabolomic fingerprinting, MIRS proves to be a promising prognostic tool for patients receiving first-line bevacizumab-based chemotherapy for mCRC.

Authors

Institutions

Publication Details

Journal
Digestive and Liver Disease
Published
2024-08-19
DOI
https://doi.org/10.1016/j.dld.2024.07.022
Citations
2
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer

William Raoul, Olivier Capitain, Jean‐Philippe Spano, Christophe Borg et al.
2 citations
Digestive and Liver Disease
Colorectal Cancer Treatments and Studies
0.57
article

Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer

William Raoul, Olivier Capitain, Jean‐Philippe Spano, Christophe Borg, Cédric Pobel, Olivier Hérault, Sylvain Manfrédi, Morgane Caulet, Olivier Sire, Aurélie Ferru, Thierry Lecomte, Maxime Guéguinou, Romain Chautard, Olivier Bouché
article en
2 citations

Abstract

By metabolomic fingerprinting, MIRS proves to be a promising prognostic tool for patients receiving first-line bevacizumab-based chemotherapy for mCRC.

Digestive and Liver DiseaseVol. 57(1)
Université de Tours (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Bretagne Occidentale (FR), Université de Bourgogne (FR), Institut Gustave Roussy (FR), Université de Bretagne Sud (FR), Université de Poitiers (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Universitaire de Reims (FR), Institut de Cancérologie de l'Ouest (FR), Centre Hospitalier Universitaire de Poitiers (FR), CHU Dijon Bourgogne (FR), Pitié-Salpêtrière Hospital (FR), Institut de Recherche Dupuy de Lôme (FR), Hôpital Robert-Debré (FR), Foie, Métabolisme, Cancer (FR), Centre de recherche Translationnelle en Médecine moléculaire (FR), Prédicteurs moléculaires et nouvelles cibles en oncologie, Niche leucémique et métabolisme oxydatif (FR), Université de Reims Champagne-Ardenne (FR)
Agence Nationale de la Recherche, Institut National Du Cancer, Société Nationale Française de Gastro-Entérologie
Good health and well-being
Openalex Percentile: Top 28%
Colorectal Cancer Treatments and Studies
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.